Islamic Finance Principles Assessment
Riba — Does HairDAO involve interest?
HairDAO shows no evidence of interest-based revenue or interest-bearing treasury holdings in the sources reviewed. Its stated income comes from pharmacy-partnership profit-sharing reinvested into R&D, and its treasury is described as IP-NFTs and patents rather than yield-bearing instruments. On riba grounds specifically, HairDAO appears low-risk, though the absence of full treasury disclosure means this cannot be verified with complete certainty.
Assessment: Moderate Riba
Score: 67.5/100
Our methodology examines 10 criteria to evaluate how well HairDAO avoids interest-based mechanisms.
HairDAO's disclosed revenue stream is profit-sharing from a "HAIR API" partnership with compounding pharmacies, with proceeds reinvested into hair-loss research rather than distributed as interest. Its treasury is described as composed of IP-NFTs and patent-linked assets tied to ongoing research value, not disclosed cash reserves, bonds, or interest-bearing instruments. No lending desks, money-market deposits, or fixed-yield products are documented. This profit-sharing-and-reinvestment structure, if accurately represented, resembles a permissible commercial royalty model rather than a riba-based one, though the lack of granular treasury breakdowns limits full verification.
The core business model is applied biotech research financing: HairDAO mints IP-NFTs to fund clinical studies (such as T3/T4 thyroid hormone research) and monetizes resulting intellectual property through pharmacy partnerships. This is fundamentally a research-and-licensing model, not a lending or borrowing operation. No documentation shows HairDAO's own protocol offering loans, margin, or guaranteed interest to token holders. A third-party aggregator's vague mention of possible "lending yield" via external DeFi pools is speculative, hedged language unconnected to HairDAO's actual documented protocol, and should not be treated as a core feature.
Gharar — How much uncertainty does HairDAO involve?
Uncertainty here is elevated but not uniform: the team is named and credentialed, and the mission (funding hair-loss research) is concrete and understandable, which reduces gharar. However, unresolved allegations about clinical-trial conduct and misrepresented affiliations, combined with an absent audit of the actual token contract, meaningfully increase uncertainty. Overall, HairDAO sits closer to the cautious end on gharar grounds.
Assessment: Moderate Gharar (Material Uncertainty)
Score: 53.8/100
Our methodology examines 15 criteria including team transparency, audit quality, and governance.
The founders, Andrew Verbinnen and Andrew Bakst, are publicly identifiable with verifiable professional histories, and additional named contributors hold credentialed medical and academic backgrounds, including a Yale-trained hair-restoration physician and an Oxford-trained computational biologist. The project maintains a public GitHub, supporting a genuine open-source posture. This transparency is a positive gharar-reducing factor. Countering it, independent reporting alleges the founders ran an unregulated clinical trial and misrepresented researcher affiliations to investors — serious, unresolved claims that introduce real doubt about disclosure quality even though no named contributor is anonymous.
No audit specific to HairDAO's own smart contract was found in the sources reviewed; the only Halborn audit retrieved pertains to an unrelated project, "Substance Exchange." This is a plain, nameable gap: HairDAO's HAIR token contract, an ERC20Burnable design with an owner-controlled mint function, has not been shown to have undergone independent third-party review. Combined with vague, templated third-party aggregator claims about staking and yield that contradict HairDAO's own governance-only token description, the overall documentation quality is inconsistent, and this unaudited status should be treated as a standing gharar concern rather than a minor omission.
Maysir — Does HairDAO involve gambling or speculation?
HairDAO's core design is not built around gambling or wagering; it exists to govern and fund biotech research. Some speculative trading naturally attaches to any listed token, particularly one this thinly traded, but that is a secondary-market behavior rather than a designed feature of the protocol. The project's own stated purpose leans away from maysir.
Assessment: Moderate Maysir (High Risk)
Score: 54.1/100
Our methodology examines 11 criteria to determine whether HairDAO is a gambling instrument or a genuine economic tool.
HairDAO's genuine utility lies in funding real clinical research — including thyroid hormone studies related to hair loss — through IP-NFTs, and operating a patient data portal that feeds an "Alpha" program rewarding users for logging treatment data. HAIR's documented function is governance participation (one token, one vote) over DAO Improvement Proposals and treasury direction, explicitly framed by the project itself as non-investment. This productive, research-funding purpose is a meaningful distinguishing factor from pure speculative or gambling-style instruments, since value creation is tied to scientific and commercial outcomes rather than zero-sum betting.
Weighed against this utility is a thin, illiquid market: circulating supply of roughly 694,921 against a fixed total of 1.53 million tokens, a market cap near $2.07 million against a fully diluted value near $19.61 million, and 24-hour volume sometimes reported at zero. This combination of low liquidity and a large uncirculated overhang creates conditions ripe for volatile, speculative trading detached from the project's stated governance purpose. Separate allegations of pump-and-dump conduct around the token add further concern. Still, since HairDAO's own design targets governance and research funding rather than wagering, secondary-market speculation by some traders does not, by itself, establish maysir in the coin's own structure.
The Full 27-Point Screening
1. Legitimacy (4 criteria)
| Criterion | Score | Analysis |
|---|
| Team Transparency | 80/100 | Founders and several core team members are named with verifiable LinkedIn profiles and credentials, making the team traceable and accountable. |
| Fraud & Scam Risk | 30/100 | Independent reporting makes specific, detailed allegations of illegal clinical trials, misrepresentation to investors, and possible securities violations, which remain unresolved. |
| Use Case Legitimacy | 70/100 | The project funds real hair-loss R&D via IP-NFTs, clinical studies, and a patient portal, showing genuine intended utility beyond hype. |
| Ethical Practices | 35/100 | Specific allegations concern the project's own conduct in funding unregulated human trials, which is a direct ethical/legal concern rather than third-party misuse of a neutral token. |
Summary: The founders and several team members are publicly named and credentialed, but independent critics allege the project's own research conduct involved unregulated human trials and possible securities-law exposure that remain unresolved.
2. Project Operations (9 criteria)
| Criterion | Score | Analysis |
|---|
| Core Protocol Business | 75/100 | The base protocol's stated business is medical research funding and governance, a sector with no inherent Shariah prohibition. |
| Transaction Fees | 50/100 (low evidence) | The sources give no reliable, consistent account of how HAIR transaction fees (if any) are burned, retained, or distributed at the protocol level. |
| Treasury Assets | 65/100 | Treasury holdings are described as IP-NFTs and patents rather than interest-bearing instruments, but this is inferred rather than explicitly confirmed as free of interest-bearing assets. |
| Revenue Model | 75/100 | Revenue is explicitly described as coming from pharmacy-partnership profits reinvested into R&D, not from interest-based activity. |
| Transparency | 70/100 | HairDAO explicitly calls itself open-source and maintains a public GitHub repository. |
| Governance | 60/100 | Governance operates via documented HIP proposal voting, though the owner-controlled token mint function indicates a centralizing counterweight. |
| Launch Fairness | 50/100 | An initial public auction is documented, but details on insider allocation or pre-launch advantage are not disclosed. |
| Token Distribution | 40/100 | Roughly half of total supply remains uncirculated with no detailed allocation/vesting breakdown available in the sources. |
| Speculation/Utility Ratio | 50/100 | The token is documented as utility/governance-purposed, yet thin trading volume and a large FDV-to-market-cap gap suggest speculative market behavior in practice. |
Summary: HairDAO operates as an open-source biotech DAO funding hair-loss research through IP-NFTs and governance voting, though its token contract retains an owner-controlled mint function that centralizes supply control.
3. Financial Health (4 criteria)
| Criterion | Score | Analysis |
|---|
| Protocol Revenue | 75/100 | Stated protocol revenue comes from pharmacy-partnership profit sharing, not riba-based lending activity. |
| Financial Status | 40/100 | Market data directly show very low trading volume and a large gap between market cap and fully diluted value, indicating financial fragility. |
| Interest Assessment | 70/100 | No documentation shows the base protocol offering native lending/borrowing; this is an inferred absence rather than an explicit confirmation. |
| Audit Quality | 10/100 | No audit of HairDAO's own smart contracts was found; the only audit retrieved in these sources belongs to an unrelated project. |
Summary: The project reports a non-interest-based revenue model from pharmacy partnerships, but trades with thin liquidity and lacks any identifiable third-party audit of its own smart contracts.
4. Token Economics (5 criteria)
| Criterion | Score | Analysis |
|---|
| Token Purpose | 70/100 | Official documentation explicitly frames HAIR as a governance-only utility token, not an investment vehicle. |
| Governance Rights | 80/100 | Governance rights are clearly documented as 1 HAIR = 1 vote within a defined proposal (HIP) process. |
| Rewards Distribution | 65/100 | A described "Alpha" mechanism ties extra HAIR rewards to user activity (data logging), suggesting variable rather than fixed rewards, though details are sparse. |
| Speculation Controls | 30/100 (low evidence) | No anti-speculation mechanisms (lockups, transfer limits, etc.) are described anywhere in the sources. |
| Asset Backing | 65/100 | The token's value is tied to IP-NFTs, patents and research outputs rather than interest-bearing collateral, though this is inferred from general project descriptions. |
Summary: HAIR is explicitly documented as a governance-only utility token with no promised financial return, though roughly half its supply remains uncirculated and no anti-speculation controls are described.
5. Staking Mechanism
HairDAO has no native staking mechanism, so these five criteria are not applicable and are excluded from the score entirely rather than counted as zeros.
Overall Assessment: HairDAO presents as a genuine, transparently-led biotech research DAO with a non-speculative governance token design, but unresolved allegations about its research conduct and a lack of any audit evidence leave notable open questions for a compliance assessment.
Written by ThanvirFounder, Ex Director S&P Global Energy
Reviewed by Imam Omar SiddiqiShariah Scholar